SCHEMBL16355153

SCHEMBL16355153

Cc1ccc(NC(=O)c2cccc(-n3cnnn3)c2)cc1C(F)(F)F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
EPHX2 P34913 1/20 0.62
KDM4E B2RXH2 3/20 0.59
USP2 O75604 2/20 0.59
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
JAK2 O60674 1/20 0.57
JAK1 P23458 1/20 0.57
ALDH1A1 P00352 3/20 0.57
POLB P06746 1/20 0.57
MAPT P10636 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
THRB P10828 1/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54
HSD17B10 Q99714 1/20 0.54
IDE P14735 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14705699 0.88 MEN1 (0.69) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL16355155 0.82 KMT2A (0.78) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL1790880 0.80 NOTUM (0.58) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL16355148 0.78 KMT2A (0.79) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL14705833 0.78 MEN1 (1.00) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL14705700 0.77 MEN1 (0.73) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL31610095 0.75 MEN1 (0.64) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL2679303 0.74 MAPT (0.55) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL23846618 0.73 EPHX2 (0.61) MEN1KMT2AEPHX2KDM4EUSP2
SCHEMBL334915 0.73 TP53 (0.71) MEN1KMT2AEPHX2KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790218-B2 Small molecule activators of calcium-activated chloride channels and methods of use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-10-17 US disclosed
US-20140378510-A1 SMALL MOLECULE ACTIVATORS OF CALCIUM-ACTIVATED CHLORIDE CHANNELS AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378510-A1 SMALL MOLECULE ACTIVATORS OF CALCIUM-ACTIVATED CHLORIDE CHANNELS AND METHODS OF USE CLCN2, KCNN1, KCNN2 MEN1 1886/4885KMT2A 4127/4885EPHX2 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.